Fenger JM - Search Results

1

Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning.

Makielski KM, Donnelly AJ, Khammanivong A, Scott MC, Ortiz AR, Galvan DC, Tomiyasu H, Amaya C, Ward KA, Montoya A, Garbe JR, Mills LJ, Cutter GR, Fenger JM, Kisseberth WC, O'Brien TD, Weigel BJ, Spector LG, Bryan BA, Subramanian S, Modiano JF. Makielski KM, et al. Among authors: fenger jm. Lab Invest. 2021 Dec;101(12):1585-1596. doi: 10.1038/s41374-021-00655-w. Epub 2021 Sep 6. Lab Invest. 2021. PMID: 34489559 Free article.

2

MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.

Fenger JM, Roberts RD, Iwenofu OH, Bear MD, Zhang X, Couto JI, Modiano JF, Kisseberth WC, London CA. Fenger JM, et al. BMC Cancer. 2016 Oct 10;16(1):784. doi: 10.1186/s12885-016-2837-5. BMC Cancer. 2016. PMID: 27724924 Free PMC article.

3

The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines.

Fossey SL, Bear MD, Lin J, Li C, Schwartz EB, Li PK, Fuchs JR, Fenger J, Kisseberth WC, London CA. Fossey SL, et al. BMC Cancer. 2011 Mar 28;11:112. doi: 10.1186/1471-2407-11-112. BMC Cancer. 2011. PMID: 21443800 Free PMC article.

4

Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.

Fenger JM, London CA, Kisseberth WC. Fenger JM, et al. ILAR J. 2014;55(1):69-85. doi: 10.1093/ilar/ilu009. ILAR J. 2014. PMID: 24936031 Review.

5

Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis.

Fenger JM, Bear MD, Volinia S, Lin TY, Harrington BK, London CA, Kisseberth WC. Fenger JM, et al. BMC Cancer. 2014 Feb 11;14:84. doi: 10.1186/1471-2407-14-84. BMC Cancer. 2014. PMID: 24517413 Free PMC article.

6

S100A4 mRNA-protein relationship uncovered by measurement noise reduction.

Athanasiou AT, Nussbaumer T, Kummer S, Hofer M, Johnston IG, Staltner M, Allmer DM, Scott MC, Vogl C, Fenger JM, Modiano JF, Walter I, Steinborn R. Athanasiou AT, et al. Among authors: fenger jm. J Mol Med (Berl). 2020 May;98(5):735-749. doi: 10.1007/s00109-020-01898-8. Epub 2020 Apr 15. J Mol Med (Berl). 2020. PMID: 32296879 Free PMC article.

7

AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit.

Lin TY, Fenger J, Murahari S, Bear MD, Kulp SK, Wang D, Chen CS, Kisseberth WC, London CA. Lin TY, et al. Blood. 2010 May 27;115(21):4217-25. doi: 10.1182/blood-2009-07-231985. Epub 2010 Mar 16. Blood. 2010. PMID: 20233974 Free PMC article.

8

MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines.

Lopez CM, Yu PY, Zhang X, Yilmaz AS, London CA, Fenger JM. Lopez CM, et al. Among authors: fenger jm. PLoS One. 2018 Jan 2;13(1):e0190086. doi: 10.1371/journal.pone.0190086. eCollection 2018. PLoS One. 2018. PMID: 29293555 Free PMC article.

9

Plasma Cytokeratin 18 and fecal Alpha-1 Antitrypsin concentrations in dogs with osteosarcoma receiving carboplatin chemotherapy.

Taikowski K, Rudinsky AJ, Louke DS, Warry E, Fenger JM. Taikowski K, et al. Among authors: fenger jm. Vet Med Sci. 2021 Mar;7(2):385-392. doi: 10.1002/vms3.392. Epub 2020 Nov 22. Vet Med Sci. 2021. PMID: 33222415 Free PMC article.

10

Dogs as a Model for Cancer.

Gardner HL, Fenger JM, London CA. Gardner HL, et al. Among authors: fenger jm. Annu Rev Anim Biosci. 2016;4:199-222. doi: 10.1146/annurev-animal-022114-110911. Epub 2015 Nov 9. Annu Rev Anim Biosci. 2016. PMID: 26566160 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page